BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Belghiti J, Cauchy F, Paradis V, Vilgrain V. Diagnosis and management of solid benign liver lesions. Nat Rev Gastroenterol Hepatol. 2014;11:737-749. [PMID: 25178878 DOI: 10.1038/nrgastro.2014.151] [Cited by in Crossref: 57] [Cited by in F6Publishing: 42] [Article Influence: 7.1] [Reference Citation Analysis]
Number Citing Articles
1 Kosters A, Abebe DF, Felix JC, Dawson PA, Karpen SJ. Inflammation-associated upregulation of the sulfated steroid transporter Slc10a6 in mouse liver and macrophage cell lines. Hepatol Res 2016;46:794-803. [PMID: 26510996 DOI: 10.1111/hepr.12609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Elbanna KY, Kielar AZ. Computed Tomography Versus Magnetic Resonance Imaging for Hepatic Lesion Characterization/Diagnosis. Clin Liver Dis (Hoboken) 2021;17:159-64. [PMID: 33868658 DOI: 10.1002/cld.1089] [Reference Citation Analysis]
3 Carnevale A, Pellegrino F, Cossu A, Ierardi AM, Parenti GC, Carrafiello G, Giganti M. Current concepts in ablative procedures for primary benign liver lesions: a step forward to minimize the invasiveness of treatment when deemed necessary. Med Oncol 2020;37:31. [PMID: 32193648 DOI: 10.1007/s12032-020-01355-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Dong W, Qiu B, Xu H, He L. Invasive management of symptomatic hepatic hemangioma. Eur J Gastroenterol Hepatol 2019;31:1079-84. [PMID: 31021878 DOI: 10.1097/MEG.0000000000001413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Myers L, Ahn J. Focal Nodular Hyperplasia and Hepatic Adenoma: Evaluation and Management. Clin Liver Dis 2020;24:389-403. [PMID: 32620279 DOI: 10.1016/j.cld.2020.04.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
6 Hoffmann K, Unsinn M, Hinz U, Weiss KH, Waldburger N, Longerich T, Radeleff B, Schirmacher P, Büchler MW, Schemmer P. Outcome after a liver resection of benign lesions. HPB (Oxford) 2015;17:994-1000. [PMID: 26456947 DOI: 10.1111/hpb.12496] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Elfrink AKE, Haring MPD, de Meijer VE, Ijzermans JNM, Swijnenburg RJ, Braat AE, Erdmann JI, Terkivatan T, Te Riele WW, van den Boezem PB, Coolsen MME, Leclercq WKG, Lips DJ, de Wilde RF, Kok NFM, Grünhagen DJ, Klaase JM; Dutch Hepato Biliary Audit Group. Surgical outcomes of laparoscopic and open resection of benign liver tumours in the Netherlands: a nationwide analysis. HPB (Oxford) 2021;23:1230-43. [PMID: 33478819 DOI: 10.1016/j.hpb.2020.12.003] [Reference Citation Analysis]
8 Cesario V, Accogli E, Domanico A, Di Lascio FM, Napoleone L, Gasbarrini A, Arienti V. Percutaneous real-time sonoelastography as a non-invasive tool for the characterization of solid focal liver lesions: A prospective study. Dig Liver Dis 2016;48:182-8. [PMID: 26687030 DOI: 10.1016/j.dld.2015.11.005] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Kim SM, Hwang S, Ahn CS, Kim KH, Moon DB, Ha TY, Song GW, Jung DH, Park GC, Hong SM. Clinicopathological features and post-resection outcomes of hepatocellular adenoma. Ann Hepatobiliary Pancreat Surg 2021;25:25-33. [PMID: 33649251 DOI: 10.14701/ahbps.2021.25.1.25] [Reference Citation Analysis]
10 Muenzel D, Daerr H, Proksa R, Fingerle AA, Kopp FK, Douek P, Herzen J, Pfeiffer F, Rummeny EJ, Noël PB. Simultaneous dual-contrast multi-phase liver imaging using spectral photon-counting computed tomography: a proof-of-concept study. Eur Radiol Exp 2017;1:25. [PMID: 29708205 DOI: 10.1186/s41747-017-0030-5] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 6.6] [Reference Citation Analysis]
11 Tran Cao HS, Marcal LP, Mason MC, Yedururi S, Joechle K, Wei SH, Vauthey J. Benign hepatic incidentalomas. Current Problems in Surgery 2019;56:100642. [DOI: 10.1067/j.cpsurg.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
12 Kim Y, Amini N, He J, Margonis GA, Weiss M, Wolfgang CL, Makary M, Hirose K, Spolverato G, Pawlik TM. National trends in the use of surgery for benign hepatic tumors in the United States. Surgery. 2015;157:1055-1064. [PMID: 25769697 DOI: 10.1016/j.surg.2015.01.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
13 Crawford D, Naidu S, Patel I, Knuttinen G, Alzubaidi S, Oklu R. Bland Embolization of Benign Liver Tumors: Review of the Literature and a Single Center Experience. J Clin Med 2021;10:658. [PMID: 33572120 DOI: 10.3390/jcm10040658] [Reference Citation Analysis]
14 Dokmak S, Aussilhou B, Rasoaherinomenjanahary F, Ronot M, Dahdouh R, Ftériche FS, Cauchy F, Paradis V, Belghiti J, Soubrane O. Hemorrhage of hepatocellular adenoma: a complication that can be treated by conservative management without surgery. HPB (Oxford) 2018;20:1198-205. [PMID: 31217088 DOI: 10.1016/j.hpb.2018.06.1796] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
15 Bedossa P, Hytiroglou P, Yeh MM. Vascular Disorders. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 636-72. [DOI: 10.1016/b978-0-7020-6697-9.00011-x] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
16 Margolskee E, Bao F, de Gonzalez AK, Moreira RK, Lagana S, Sireci AN, Sepulveda AR, Remotti H, Lefkowitch JH, Salomao M. Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis. Diagn Pathol. 2016;11:27. [PMID: 26961851 DOI: 10.1186/s13000-016-0475-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
17 Zhu C, Luo X, Wu J, Liu Y, Liu L, Ma S, Xie R, Wang S, Ji W. TM4SF1, a binding protein of DVL2 in hepatocellular carcinoma, positively regulates beta-catenin/TCF signalling. J Cell Mol Med 2021;25:2356-64. [PMID: 31876386 DOI: 10.1111/jcmm.14787] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
18 McDermott C, Ertreo M, Jha R, Ko J, Fernandez S, Desale S, Fishbein T, Satoskar R, Winslow E, Smith C, Hsu CC. Risk factors for bleeding hepatocellular adenoma in a United States cohort. Liver Int 2021. [PMID: 34687281 DOI: 10.1111/liv.15087] [Reference Citation Analysis]
19 Ilhan M, Oner G, Gök AF, Bulakçı M, Yeğen G. Treatment of atypically-localized cavernous hemangioma in abdomen with atypical pain. Int J Surg Case Rep 2016;25:24-7. [PMID: 27315430 DOI: 10.1016/j.ijscr.2016.05.058] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
20 Matos AP, Velloni F, Ramalho M, AlObaidy M, Rajapaksha A, Semelka RC. Focal liver lesions: Practical magnetic resonance imaging approach. World J Hepatol 2015; 7(16): 1987-2008 [PMID: 26261689 DOI: 10.4254/wjh.v7.i16.1987] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 4.7] [Reference Citation Analysis]
21 Strauss E, Ferreira Ade S, França AV, Lyra AC, Barros FM, Silva I, Garcia JH, Parise ER. Diagnosis and treatment of benign liver nodules: Brazilian Society of Hepatology (SBH) recommendations. Arq Gastroenterol 2015;52 Suppl 1:47-54. [PMID: 26959805 DOI: 10.1590/S0004-28032015000500003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
22 Chen W, Liu Y, Zhuang Y, Peng J, Huang F, Zhang S. Hepatic perivascular epithelioid cell neoplasm: A clinical and pathological experience in diagnosis and treatment. Mol Clin Oncol 2017;6:487-93. [PMID: 28413654 DOI: 10.3892/mco.2017.1168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
23 Bise S, Frulio N, Hocquelet A, Alberti N, Blanc JF, Laurent C, Laumonier H, Balabaud C, Bioulac-Sage P, Trillaud H. New MRI features improve subtype classification of hepatocellular adenoma. Eur Radiol 2019;29:2436-47. [PMID: 30523457 DOI: 10.1007/s00330-018-5784-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
24 Krause K, Tanabe KK. A Shifting Paradigm in Diagnosis and Management of Hepatic Adenoma. Ann Surg Oncol 2020;27:3330-8. [PMID: 32542565 DOI: 10.1245/s10434-020-08580-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Neuberger J, Cain O. The Need for Alternatives to Liver Biopsies: Non-Invasive Analytics and Diagnostics. Hepat Med 2021;13:59-69. [PMID: 34163263 DOI: 10.2147/HMER.S278076] [Reference Citation Analysis]
26 Firouznia K, Ghanaati H, Alavian SM, Nassiri Toosi M, Ebrahimi Daryani N, Jalali AH, Shakiba M, Hosseinverdi S. Management of liver hemangioma using trans-catheter arterial embolization. Hepat Mon. 2014;14:e25788. [PMID: 25737731 DOI: 10.5812/hepatmon.25788] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
27 Reizine E, Ronot M, Pigneur F, Purcell Y, Mulé S, Dioguardi Burgio M, Calderaro J, Amaddeo G, Laurent A, Vilgrain V, Luciani A. Iso- or hyperintensity of hepatocellular adenomas on hepatobiliary phase does not always correspond to hepatospecific contrast-agent uptake: importance for tumor subtyping. Eur Radiol 2019;29:3791-801. [DOI: 10.1007/s00330-019-06150-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Tsilimigras DI, Rahnemai-azar AA, Ntanasis-stathopoulos I, Gavriatopoulou M, Moris D, Spartalis E, Cloyd JM, Weber SM, Pawlik TM. Current Approaches in the Management of Hepatic Adenomas. J Gastrointest Surg 2019;23:199-209. [DOI: 10.1007/s11605-018-3917-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
29 Ardito F, Aldrighetti L, Guglielmi A, Jovine E, Cillo U, Ferrero A, De Carlis L, Belli G, Dalla Valle R, Slim A, Mazzaferro V, Navarra G, Ettorre GM, Calise F, Pinna AD, Giuliante F; Italian Group of Minimally Invasive Liver Surgery (I Go MILS). Surgical Management of Hepatic Benign Disease: Have the Number of Liver Resections Increased in the Era of Minimally Invasive Approach? Analysis from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry. J Gastrointest Surg 2020;24:2233-43. [DOI: 10.1007/s11605-019-04260-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
30 Lee M, Choi JY, Lim JS, Park MS, Kim MJ, Kim H. Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas. Angiogenesis. 2016;19:147-153. [PMID: 26816001 DOI: 10.1007/s10456-016-9494-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Reizine E, Ronot M, Ghosn M, Calderaro J, Frulio N, Bioulac-Sage P, Trillaud H, Vilgrain V, Paradis V, Luciani A. Hepatospecific MR contrast agent uptake on hepatobiliary phase can be used as a biomarker of marked β-catenin activation in hepatocellular adenoma. Eur Radiol 2021;31:3417-26. [PMID: 33146794 DOI: 10.1007/s00330-020-07434-z] [Reference Citation Analysis]
32 Taimr P, Bröker MEE, Dwarkasing RS, Hansen BE, de Knegt RJ, De Man RA, IJzermans JNM. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound. Ultrasound Med Biol 2017;43:2144-50. [PMID: 28743375 DOI: 10.1016/j.ultrasmedbio.2017.05.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
33 Shapira N, Fokuhl J, Schultheiß M, Beck S, Kopp FK, Pfeiffer D, Dangelmaier J, Pahn G, Sauter AP, Renger B, Fingerle AA, Rummeny EJ, Albarqouni S, Navab N, Noël PB. Liver lesion localisation and classification with convolutional neural networks: a comparison between conventional and spectral computed tomography. Biomed Phys Eng Express 2020;6:015038. [DOI: 10.1088/2057-1976/ab6e18] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
34 Baba T, Kawano T, Saito Y, Onishi S, Yamada K, Yamada W, Masuya R, Nakame K, Kawasaki Y, Iino S, Sakoda M, Kirishima M, Kaji T, Tanimoto A, Natsugoe S, Ohtsuka T, Moritake H, Ieiri S. Malignant perivascular epithelioid cell neoplasm in the liver: report of a pediatric case. Surg Case Rep 2021;7:212. [PMID: 34542724 DOI: 10.1186/s40792-021-01300-w] [Reference Citation Analysis]
35 Nemoto S, Ariizumi SI, Kotera Y, Omori A, Yamashita S, Kato TA, Aoyama S, Egawa H, Yamamoto M. Inflammatory hepatocellular adenoma in a patient with Turner's syndrome: A case report. Int J Surg Case Rep. 2019;56:5-9. [PMID: 30798096 DOI: 10.1016/j.ijscr.2019.02.017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
36 Tsekouras K, Spartalis E, Mamakos N, Tsourouflis G, Nikiteas NI, Dimitroulis D. The Use of Robotics in Surgery of Benign Liver Diseases: A Systematic Review. Surg Innov 2021;:15533506211031414. [PMID: 34275339 DOI: 10.1177/15533506211031414] [Reference Citation Analysis]
37 Védie AL, Sutter O, Ziol M, Nault JC. Molecular classification of hepatocellular adenomas: impact on clinical practice. Hepat Oncol 2018;5:HEP04. [PMID: 30302195 DOI: 10.2217/hep-2017-0023] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
38 Margonis GA, Ejaz A, Spolverato G, Rastegar N, Anders R, Kamel IR, Pawlik TM. Benign solid tumors of the liver: management in the modern era. J Gastrointest Surg 2015;19:1157-68. [PMID: 25560181 DOI: 10.1007/s11605-014-2723-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
39 Heinrich S, Tripke V, Huber T, Mittler J, Lang H. A Match-Pair Analysis of Open Versus Laparoscopic Liver Surgery. JSLS 2017;21:e2017. [PMID: 29326529 DOI: 10.4293/JSLS.2017.00061] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
40 Balabaud C, Laurent C, Frulio N, Marie Christine SP, Le Bail B, Possenti L, Blanc JF, Chiche L, Bioulac-sage P. Repeat surgery in HNF1alpha-inactivated adenomatosis. Clinics and Research in Hepatology and Gastroenterology 2019;43:460-7. [DOI: 10.1016/j.clinre.2018.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 van Rosmalen BV, de Graeff JJ, van der Poel MJ, de Man IE, Besselink M, Abu Hilal M, Busch OR, Verheij J, van Gulik TM; Dutch Benign Liver Tumour Group. Impact of open and minimally invasive resection of symptomatic solid benign liver tumours on symptoms and quality of life: a systematic review. HPB21:1119-1130. [PMID: 30926331 DOI: 10.1016/j.hpb.2019.02.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Nault JC, Couchy G, Caruso S, Meunier L, Caruana L, Letouzé E, Rebouissou S, Paradis V, Calderaro J, Zucman-Rossi J. Argininosuccinate synthase 1 and periportal gene expression in sonic hedgehog hepatocellular adenomas. Hepatology 2018;68:964-76. [PMID: 29572896 DOI: 10.1002/hep.29884] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
43 Nault JC, Paradis V, Cherqui D, Vilgrain V, Zucman-Rossi J. Molecular classification of hepatocellular adenoma in clinical practice. J Hepatol. 2017;67:1074-1083. [PMID: 28733222 DOI: 10.1016/j.jhep.2017.07.009] [Cited by in Crossref: 71] [Cited by in F6Publishing: 60] [Article Influence: 14.2] [Reference Citation Analysis]
44 Sousa CMN, Gadelha PMM, Cartaxo RS, Pedrosa GWH, Honorio RS, Lima JMC, Coelho GR, Coelho CR. Hepatocyte Nuclear Factor 1α-Mutated Hepatocellular Adenomas: An Atypical Presentation. Case Rep Gastroenterol 2017;11:637-42. [PMID: 29282384 DOI: 10.1159/000480376] [Reference Citation Analysis]